WALGREENS AND CVS JOIN WALMART IN CARRYING BLEEDSTOP™, A NEW FIRST AID PRODUCT

SAINT PAUL, MN, USA, April 14, 2020 /EINPresswire.com/ — In the past two to three weeks, Walgreens and CVS are now making BleedStop™ available to their customers, as Walmart has done for the past 3 years. This is significant as BleedStop™, a blood coagulant, is clinically proven to stop bleeding quickly. BleedStop™ will now be available to virtually the entire US population as at least one of these three retail chains is conveniently located close to almost every neighborhood. The FDA has not only cleared BleedStop™ for a topical indication to be sold to consumers, but in addition has given clearance for BleedStop™ to be utilized for moderate to severe bleeding wounds by Rx prescription. Emergency Rooms and First Responders along with Law Enforcement now have a new tool available to them for moderate to even severe bleeding wounds. Most remarkably, the FDA has granted BleedStop™ a “SAFE IN THE WOUND” labeling claim, which no other product available on the market to consumers, Law Enforcement or First Responders has ever been granted. Other traditional products on the market, sold as a method to help stop bleeding, must be removed from the wound after use.

In addition to everyday consumers, BleedStop™ has been proven effective for the millions of people and growing population of patients on Blood Thinners. The result, BleedStop™ is preventing many otherwise necessary trips to the ER because of its effectiveness and because it is “SAFE IN THE WOUND.” Walgreens felt this was an important labeling claim granted by the FDA which their clinical investigation team verified prior to its decision to make BleedStop™ available to its customers.

Lou Ferrigno, an active Deputy Sheriff, First Responder, most notably known as “The Incredible Hulk” and Mr. Universe told CBS The Doctors television program panel while doing a segment with them, “I guarantee you that this product will change First Aid forever.” Instead of just applying pressure to a cut or wound, BleedStop™ will be applied first to actively clot the blood and to stop the bleeding quickly.

“Many people who were bleeding severely and would have otherwise bled out, have had their lives saved due to our technology,” said Patrick Spearman, CEO of CoAg Medical/BleedStop™. “We believe that our many studies including our published results in a major medical journal [The American College of Emergency Physicians, Am Emerg Med 2009; 53:804-810] along with our clinical data and field experiences, prove that BleedStop™ is the most effective blood coagulant ever available to the public, First Responders, Law Enforcement and to the Military for stopping bleeding.”

Shelly Amann, President of CoAg Medical/BleedStop™ stated, “Blood thinner patients require BleedStop™ for their personal safety. Likewise, every Emergency Room should have BleedStop™ available to them so they can properly treat their patients who are forced to the ER when continuously bleeding even from a tiny cut due to being on blood thinners. In addition to our powder that conforms to most wounds perfectly, BleedStop™ is also available in a pliable rigid foam configuration for NOSEBLEEDS, shaving nicks or cuts, and in oral applications (inside the mouth), or other inconvenient areas to apply powder. BleedStop™ foam carries the same ‘SAFE IN THE WOUND’ FDA allowed labeling claim and provides the same effectiveness as our powder for stopping bleeding fast. It truly is revolutionary.”

BleedStop™ is manufactured 100% in the USA and has been approved worldwide in countries such as India, 10 Middle Eastern countries, parts of Africa and Mexico. CE Mark/European approval is pending.

www.bleedstop.com
www.coagmedical.com
Patrick Spearman, CEO 651-315-4583 pspearman@coagmedical.com
Shelly Amann, President 651-315-4588 samann@coagmedical.com

Patrick Spearman
CoAg Medical LLC
+1 651-315-4583
email us here


Source: EIN Presswire

MIND ALGN Treats Local Hospital Workers to Dinner During COVID-19 Pandemic

Staff at Shady Grove Medical Center enjoy dinner from Quincy’s Bar & Grill, compliments of the local MIND ALGN TMS Clinic as a show of support and solidarity for local healthcare workers during the COVID-19 pandemic

Teaming up with Quincy's Bar & Grill, the Bethesda-based TMS clinic showed support & appreciation for local healthcare workers on the front line of the crisis

BETHESDA, MARYLAND, USA, April 14, 2020 /EINPresswire.com/ — MIND ALGN, a healthcare company pioneering the use of Magnetic e-Resonance Therapy (MeRTˢᴹ) leveraging Transcranial Magnetic Stimulation (TMS), has joined forces with Quincy’s Bar & Grill in Gaithersburg, Maryland to provide meals to the staff of the ICU department at Adventist HealthCare Shady Grove Medical Center during the COVID-19 Pandemic.

Adventist HealthCare’s Shady Grove campus is located in Montgomery County, the second hardest hit county in Maryland with about 20% of the state’s reported positive COVID-19 cases, according to the state’s COVID-19 Data Dashboard. The growing number of patients is taxing the state’s healthcare system, with doctors and nurses at the front lines. Despite shortages of equipment and supplies, these healthcare workers bravely continue to fight against the Coronavirus while putting their very lives in danger. “In these scary and uncertain times, we all need to be comforted. And what’s more comforting than food? We really appreciate it!” commented one ICU staffer.

“Nurses are heroes who selflessly take care of others every day, so we wanted to do our small part to take care of them for a change,” said Courtney Hejl, MIND ALGN’s Business Manager. “Their jobs are never easy, but we hope that this gesture demonstrates our appreciation and perhaps inspires others to support our healthcare community during this crisis and in the future.”

Complying with Maryland Governor Larry Hogan’s state-wide Stay at Home order to protect public health and safety during the COVID-19 pamdemic, MIND ALGN has temporarily closed its Bethesda clinic. However, given the strict social distancing measures in place, health experts anticipate an even greater demand for depression treatments like MIND ALGN TMS therapy post-quarantine. In the meantime, the team at MIND ALGN will continue to show solidarity with the local healthcare community. “Doctors and nurses are our partners in bringing life-changing MIND ALGN TMS therapy to those suffering from depression and other neurological issues,” said Mark Tornillo, MIND ALGN’s Founder, “And we support our partners.”

####

ABOUT MIND ALGN
MIND ALGN is a healthcare company pioneering the use of Magnetic e-Resonance Therapy (MeRTˢᴹ), a patented, non-invasive, non-pharmaceutical approach to neuromodulation leveraging Transcranial Magnetic Stimulation (TMS) and individualized treatment plans to restore brain health and performance. MIND ALGN is an authorized licensee of the Wave Neuroscience’s patented MeRT technology approach to neuromodulation. The MeRT approach is unique as it provides therapy specifically tailored to meet the needs of the individual, resulting in a healthier, better performing brain.

CONTACT MIND ALGN
If you would like additional information about MIND ALGN, visit mindalgn.com or contact us:
MIND ALGN
7920 Norfolk Avenue
Suite 950
Bethesda, Maryland 20814

Courtney Hejl
MIND ALGN
+1 301-657-4567
email us here
Visit us on social media:
Facebook
LinkedIn


Source: EIN Presswire

EMDR Therapist Dianne Pulsipher to be Featured on Close Up Radio

HOUSTON, TEXAS, UNITED STATES, April 14, 2020 /EINPresswire.com/ — We go through many distressing and dramatic life experiences that can affect us physically and emotionally. Often, we turn to drugs and alcohol to cope which unfortunately leads to addiction and further complications. Talk therapy can be effective but sometimes may take years to process. We are all seeking permanent relief from our pain and suffering so where can we actually find a long-term solution to our problems?

Dianne is a top notch Certified EMDR therapist specializing in trauma.

“EMDR is absolutely groundbreaking because it completely helps to clear out the trauma,” says Dianne. “Most people who seek out EMDR have tried many different modalities but have not gotten better and not only is EMDR effective, but it’s life changing where people become truly more joyful. There is way too much trauma out in the world and now more than ever the entire universe is traumatized and we need deep, serious profound healing.”

Developed by psychologist, Francine Shapiro, EMDR, which stands for Eye Movement Desensitization and Reprocessing, is rapidly gaining popularity across the country to treat anything from mental health issues, to trauma, addictions, anxiety, eating disorders, and panic attacks. In an EMDR procedure, the therapist performs specific eye movements, taps, or other modalities that create bilateral stimulation. Every case is different and unique. These swift eye movements release our bad memories and allow negative thoughts to be constructively recycled and obliterated.

Whether we suffer from a past trauma like being bullied in school, were sexually abused, or suffer from anxiety, every distressing event can deeply wound us. Evidence is clear that our upbringing matters very much which determines our behavior patterns throughout the course of our lifetime. Whether the way we raised was one of neglect or abuse or we were nurtured and loved, it affects our well-being. This is defined as attachment which begins in the uterus and determines our nature, how we perceive the world and behave towards others.

Attachment is the relationship between children and their caretakers. There are four behavioral patterns of attachment: secure, avoidant, ambivalent, and disorganized. The ideal one is secure attachment where a child is ready to explore the world because their parents were strong role models.

Ambivalent attachment is when parents inconsistently give love and support to their children and so they grow up trying to please people. Avoidant attachment is when parents basically ignored or were mean to their children, so in relationships these individuals will refrain from getting too close to people. In disorganized attachment, a fear-based attachment, parents were either frightened or frightening. These individuals will have experienced the worst type of trauma.

“The wonderful news is that is you can develop secure attachment as an adult because trauma and attachment are linked hand in hand,” says Dianne. “The deeper you experience the healing process the more you are able to heal your trauma and so when you can get better through your attachment and trauma work then you learn how to find people that are really supportive of you.”

Dianne says through the powerful effectiveness of EMDR we can change the way we see ourselves which is life changing and awe inspiring. If once you had the belief ‘I’m not good enough,’ you then realize that you are, and that you matter, and it literally transforms your negative thoughts and perceptions into healthy positive ones.

“It is critical that people seek out only experienced EMDR therapists because if they have only had basic EMDR training and no further trauma training, they can actually retraumatize the client,” says Dianne. “EMDR is a very powerful tool and as a therapist you need to be cognizant in what you are doing, and this is why I’m continually training and learning practical tools to better understand trauma.”

Depending on the level of trauma, the trauma can be cleared in 8 to 10 sessions or can take several years.

Dianne immensely enjoys her work and is honored she gains the trust of her clients to confide in her their most extreme vulnerabilities.

“We all experience a certain degree of trauma,” says Dianne. “If there’s a way we can be more mindful, passionate, and compassionate with each another we can become more tolerant cause we understand that we all go through hardships. Everyone in the world should be in therapy, we don’t have to be diagnosed with a mental health issue. With EMDR we can find who we are and help us get to the root of our problem so we can truly find happiness even in our darkest times.”

Close Up Radio will feature Dianne Pulsipher in an interview with Jim Masters on Thursday April 16th at 11 a.m. EST

Listen to the show on BlogTalkRadio

If you have any questions for our guest, please call (347) 996-3389

For more information on our guest please visit www.diannepulsipher.com

Written By: Beatrice Maria Centeno

Lou Ceparano
Close Up Television & Radio
+ +1 (631) 850-3314
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Dr. Patricia A. Broderick of Eazysense Nanotechnologies Inc. to be Featured on Close Up Radio

NEW YORK, NEW YORK, UNITED STATES, April 14, 2020 /EINPresswire.com/ — In 2014, the actor and comedian Robin Williams committed suicide.

Williams had a long, documented history of clinical depression associated with Parkinson’s disease. However, it was later found during his autopsy that 40% of the neurotransmitter dopamine in the motor neurons of his brain was missing. Lewy bodies were also found in his brain, but again they were only discovered postmortem, after death.

One woman is looking to change all that: Dr. Patricia Broderick. Thanks to remarkable advances by dedicated, innovative and open-minded scientists like Dr. Patricia Broderick., we’re getting closer to understanding the brain, both biologically and chemically.

Dr. Broderick is a Medical Professor in Molecular Cellular and Biomedical Sciences at The City University of New York School of Medicine. Associated with NYU Comprehensive Epilepsy Center and the Department of Neurology at NYU-Langone Medical Center, Dr. Broderick has contributed novel surgical interventions for neurodegenerative diseases intraoperatively. Dr. Broderick is the Director of an innovative, creative Interdisciplinary Course, called Neurobiological Aspects of Drugs of Abuse for all undergrads at The City College of New York within the CUNY School of Medicine.

Dr. Broderick is the first person to marry the brain with nanosensors to discover all new ways to treat the brain.

Dr. Broderick has invented, patented and trademarked a revolutionary technology that will change the way we understand the brain: The BRODERICK PROBE®, about which medical doctors have published, could change the face of science and medicine.

“We can see inside the brain as no one else can in the entire world,” says Dr. Broderick. “Our technology senses the neurotransmitters in the brain to compare the differences in neurochemistry between the natural state with the brain disorder that we want to heal.”

The founder of Eazysense Nanotechnologies Inc., Dr. Broderick has spent a career working on neurodegenerative diseases like epilepsy, Parkinson's and Alzheimer's, as well as biopsychiatric conditions like anxiety, depression, schizophrenia, schizoaffective disorders. Dr. Broderick is known worldwide as a unique pioneer in nanobiotechnology, leading the frontier in nanosensing biochemistry in the brain to alleviate the burden of these brain disorders. Patricia’s next book, a monograph, release date, June 30, 2020 is entitled Neuroimaging, Sensing Biochemistry in the Brain.

The work of Broderick and her team has led the way in Neuropsychopharmacology with direct extrapolation to what has and is happening globally to what she has coined: “The Covid Brain.”

“Have you ever taken an absolutely beautiful picture of yourself and you look like a movie star, but two weeks later somebody takes a picture and the lighting's not right,” says Dr. Broderick. “Magnetic resonance imaging has done marvelous things, but it can’t see white matter. The patient comes out believing there's nothing wrong with their brain. The photographing of white matter in the brain is difficult with the MRI, not at all difficult with the Broderick approach. We’re looking inside the brain.”

Close Up Radio will feature Dr. Patricia Broderick in an interview with Jim Masters on April 16th at 4pm EDT and with Doug Llewelyn on April 23rd at 4pm EDT

Listen to the show on BlogTalkRadio

If you have a question for our guest, call (347) 996-3389

Lou Ceparano
Close Up Television & Radio
+ +1 (631) 850-3314
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Watchdog Questions if Psychiatric Drugs are Predisposing Patients to CV19 Deaths

psychiatric drugs

As psychiatric hospitals start reporting COVID-19 deaths, CCHR has concerns over psychotropic drug adverse effects on immune system, potentially predisposing patients to viruses. Condemns novel LSD & psychedelic drug treatment research for pandemic-related “depression.”

As psychiatric hospitals start reporting COVID-19 deaths, CCHR has concerns over psychotropic drug adverse effects on immune system

It would be tragic if natural 'fears' of the virus are redefined as 'mental disorders' and treated by unregulated psychiatric and psychological practices.”

— CCHR International

LOS ANGELES, CALIFORNIA, UNITED STATES, April 14, 2020 /EINPresswire.com/ — It is undeniable that the challenges facing us all during the COVID-19 pandemic are staggering. But juxtaposed against the positive mantra, “We’ll get through this together,” is the chaos-mongering that people “will battle psychological scars for years,” requiring psychiatric or psychological treatment. Citizens Commission on Human Rights, an international mental health industry watchdog says it would be tragic if natural “fears” of the virus are redefined as “mental disorders” and treated by unregulated psychiatric and psychological practices.

This includes treatment such as physically damaging psychotropics and psychedelics like LSD to treat depression “predicted” to arise from the pandemic.

Mirsad Serdarevic, Ph.D., writing in Psychology Today, noted: “Over the past several decades, psychiatric practice has been almost exclusively reduced to psychopharmaceutical practice, which either leads to or contributes to physical deterioration of the population it purports to be treating.” This includes the larger population being prescribed antidepressants which can cause weight gain and could “contribute, if not lead, to development of obesity, one of the risk factors associated with COVID-19 disease complications and mortality.”[1]

CCHR questions whether the drug practices in psychiatric hospitals could predispose patients to COVID-19. New Jersey recently reported four patients died from COVID-19 in psychiatric hospitals.[2] Thirteen patients tested positive at Western State Hospital in Kentucky.[3] Clinical reports indicate that patients treated with atypical antipsychotics are more susceptible to infections.[4] The antipsychotic clozapine poses a risk of lowering immune system function.[5] Taking neuroleptics, lithium, psychostimulants and tranquilizers can weaken the immune system. The FDA warns that lamotrigine prescribed as a mood stabilizer “can cause a rare but very serious reaction” to the immune system which “can cause severe inflammation throughout the body and lead to hospitalization and death.”[6]

A New York psychiatrist told ABC News, “It is certainly reasonable to expect the risk of suicide increasing secondary to the economic and social fallout" of COVID-19.[7] With already one in six American adults taking a psychiatric drug, the impact of increasing this is foreboding. According to a researcher at Boulder County Public Health and the Colorado School of Public Health, “A majority of suicide attempts involve the use of medication.” The main exposure was individuals in the sample study who filled a psychotropic drug prescription within 90 days before the suicide attempt.[8]

Antidepressants top the list of psychotropics Americans take, followed by sedatives, hypnotics and anti-anxiety drugs, then antipsychotics.[9] Another 6.7 million 0-17-year-olds are prescribed psychotropic drugs, of which 2.1 million are taking antidepressants that the FDA warns against prescribing to because of the risk of suicide.[10] Other recognized side effects include anxiety, agitation and nervousness, vivid dreaming and withdrawal effects.[11]

A recent Psychology Today article warns of potential overprescribing of SSRI antidepressants “due in part to coronavirus-related stress and anxiety on a scale felt worldwide,” but says it is especially important to be reminded that COVID-19 is not a mental health crisis. As Dr. Lucy Johnstone explains, “It's healthy to be afraid in a crisis” and “wrong to view our natural fears as mental health disorders.”[12]

CCHR is tracking the increased volume of psychiatric promotion that “depression,” “anxiety” and suicide are likely to soar and questions the potential conflicts of interests behind these warnings.

A psychiatrist representing the American Association for Emergency Psychiatry warned that the “real mental health crisis” is yet to come, that “we’re on the precipice of [an increase in demand].” This psychiatrist has conflicts of interest with five psychotropic drug manufacturers, including stock holdings in a company that makes antipsychotics.

Newsweek reported that a study being conducted at the Imperial College in London will soon finish a trial comparing psilocybin with the antidepressant drug escitalopram on patients with depression. The lead researcher has financial ties to at least seven psychiatric drug companies and has received grants or clinical trial payments from P1vital (research company for CNS treatment development and mental health), which he also has share options in.

An American Psychiatric Association’s blog said a “new review study concludes” that psychedelics such LSD “show promise for treating conditions including treatment-resistant depression, anxiety and posttraumatic stress disorder (PTSD).” The research team included at least four psychiatrists with strong ties to psychotropic drug makers.

CCHR wants consumers to be better informed of psychotropic drug risks through its free psychiatric drugs side effects database.

CCHR is the mental health watchdog responsible for more than 180 laws that now protect patients from damaging practices. DONATE to support its work here: https://www.cchrint.org/cchrint-donate/

References:

[1] Mirsad Serdarevic Ph.D., “When Medications Hurt: How the COVID-19 crisis highlights serious problems with psychiatric treatment,” Psychology Today, 11 Apr. 2020, https://www.psychologytoday.com/us/blog/sound-bell/202004/when-medications-hurt

[2] https://www.trentonian.com/news/nj-health-officials-four-patients-dead-dozens-sickened-by-covid-19-at-psych-hospitals-trenton/article_0268deb2-78f4-11ea-a69a-2b863cbf6d78.html

[3] https://hoptownchronicle.org/covid-19-cases-up-to-29-at-western-state-hospital-16-employees-among-those-testing-positive

[4] https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0218937

[5] “The most serious side effect associated with CLOZARIL is called agranulocytosis. This occurs when your white blood cell count is significantly lowered and your body’s immune system becomes highly vulnerable to infection,” http://clozaril.com/?page_id=31

[6] https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-serious-immune-system-reaction-seizure-and-mental-health

[7] “Unemployment, isolation: COVID-19's mental health impact: The current pandemic is not just a medical tragedy,” ABC News, 7 Apr. 2020, https://abcnews.go.com/Health/unemployment-isolation-covid-19s-mental-health-impact/story?id=69939700

[8] “Prescribed access to psychotropic drugs linked to suicide method choice,” Brown TL, et al. J Clin Psychiatry. 2018;doi:10.4088/JCP.17m11982, Healio Psychiatry, 20 Nov. 2018, https://www.healio.com/psychiatry/suicide/news/online/%7B50b36f43-f617-4d1c-beea-4d5d48b9c05a%7D/prescribed-access-to-psychotropic-drugs-linked-to-suicide-method-choice

[9] “1 in 6 Americans Takes a Psychiatric Drug: Antidepressants were most common, followed by anxiety relievers and antipsychotics,” Scientific American, 13 Dec. 2016, https://www.scientificamerican.com/article/1-in-6-americans-takes-a-psychiatric-drug/

[10] https://www.cchrint.org/psychiatric-drugs/children-on-psychiatric-drugs/

[11] https://www.drugwatch.com/ssri/prozac/; https://www.health.harvard.edu/diseases-and-conditions/going-off-antidepressants

[12] “Antidepressants and Online Misinformation: A study of medical websites finds widespread misreporting,” Psychology Today, 13 Apr. 2020, https://www.psychologytoday.com/ca/blog/side-effects/202004/antidepressants-and-online-misinformation

Amber Rauscher
Citizens Commission on Human Rights
+1 323-467-4242
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

Isolation Suit Market Major Manufacturers, Trends, Sales, Supply, Demand, Share Analysis to 2026

New Study Reports "Isolation Suit Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026" has been Added on WiseGuyReports.

PUNE, MAHARASHTRA, INDIA, April 14, 2020 /EINPresswire.com/ — Isolation Suit Market 2020-2026

New Study Reports "Isolation Suit Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026" has been Added on WiseGuyReports.

Introduction/Report Summary:

This report provides in depth study of “Isolation Suit Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Isolation Suit Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Drivers and Constraints

The fundamental dynamics that are explored in the report hold substantial influence over the Isolation Suit market. The report further studies on the value, volume trends, and the pricing history of the market. In addition to it, various growth factors, restraints, and opportunities are also analyzed for the market to study the in-depth understanding of the market.

Key Players

The report has profiled some of the Important players prevalent in the global like – Cardinal Health, Dupont
Dukal Corporation
Molnlycke
Owens & Minor
Medline Industries
RCR International
Derekduck, and more.

This report covers the sales volume, price, revenue, gross margin, manufacturers, suppliers, distributors, intermediaries, customers, historical growth and future perspectives in the Isolation Suit.

Request for Free Sample Report of “Isolation Suit” Market @  https://www.wiseguyreports.com/sample-request/5169772-global-isolation-suit-market-research-report-2020

Market Segmentation based On Type, Application and Region:

The global Isolation Suit is analyzed for different segments to arrive at an insightful analysis. Such segmentation has been done based on type, application, and region.

Based on type, the global Isolation Suit Market is segmented into Full-isolated Isolation Suit, Backless Isolation Suit and other

Based on application, the Isolation Suit Market is segmented into Electronic Industry, Pharmaceutical Industry, Food Industry, Biological Industry, Aerospace, and Others.

Based on Detailed Regional Analysis, the regional segmentation has been carried out for regions of U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America. The report on WGR includes an in-depth study of the Isolation Suit in each regional segment mentioned above.

Key Stakeholders 
Isolation Suit Market Manufacturers 
Isolation Suit Market Distributors/Traders/Wholesalers 
Isolation Suit Market Subcomponent Manufacturers 
Industry Association 
Downstream Vendors

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/5169772-global-isolation-suit-market-research-report-2020

Major Key Points from Table of Content:

1 Isolation Suit Market Overview
1.1 Product Overview and Scope of Isolation Suit
1.2 Isolation Suit Segment by Type
1.2.1 Global Isolation Suit Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Full-isolated Isolation Suit
1.2.3 Backless Isolation Suit
1.3 Isolation Suit Segment by Application
1.3.1 Isolation Suit Sales Comparison by Application: 2020 VS 2026
1.3.2 Electronic Industry
1.3.3 Pharmaceutical Industry
1.3.4 Food Industry
1.3.5 Biological Industry
1.3.6 Aerospace
1.3.7 Others
1.4 Global Isolation Suit Market Size Estimates and Forecasts
1.4.1 Global Isolation Suit Revenue 2015-2026
1.4.2 Global Isolation Suit Sales 2015-2026
1.4.3 Isolation Suit Market Size by Region: 2020 Versus 2026

2 Market Competitions by Manufacturers

3 Production Capacities by Region

6 Company Profiles and Key Figures in Isolation Suit Business
6.1 Cardinal Health
6.1.1 Corporation Information
6.1.2 Cardinal Health Description, Business Overview and Total Revenue
6.1.3 Cardinal Health Isolation Suit Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Cardinal Health Products Offered
6.1.5 Cardinal Health Recent Development
6.2 Dupont
6.2.1 Dupont Isolation Suit Production Sites and Area Served
6.2.2 Dupont Description, Business Overview and Total Revenue
6.2.3 Dupont Isolation Suit Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Dupont Products Offered
6.2.5 Dupont Recent Development
6.3 Dukal Corporation
6.3.1 Dukal Corporation Isolation Suit Production Sites and Area Served
6.3.2 Dukal Corporation Description, Business Overview and Total Revenue
6.3.3 Dukal Corporation Isolation Suit Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Dukal Corporation Products Offered
6.3.5 Dukal Corporation Recent Development
6.4 Molnlycke
6.4.1 Molnlycke Isolation Suit Production Sites and Area Served
6.4.2 Molnlycke Description, Business Overview and Total Revenue
6.4.3 Molnlycke Isolation Suit Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Molnlycke Products Offered
6.4.5 Molnlycke Recent Development

and more

Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Continued…

NORAH TRENT
Wise Guy Reports
841-198-5042
email us here


Source: EIN Presswire

R95 & R100 Grade Protective Masks Market Major Manufacturers, Trends, Sales, Supply, Demand, Share Analysis to 2026

New Study Reports "R95 & R100 Grade Protective Masks Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026" has been Added.

PUNE, MAHARASHTRA, INDIA, April 14, 2020 /EINPresswire.com/ — R95 & R100 Grade Protective Masks Market 2020-2026

New Study Reports "R95 & R100 Grade Protective Masks Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026" has been Added on WiseGuyReports.

Introduction/Report Summary:

This report provides in depth study of “R95 & R100 Grade Protective Masks Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The R95 & R100 Grade Protective Masks Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Drivers and Constraints

The fundamental dynamics that are explored in the report hold substantial influence over the R95 & R100 Grade Protective Masks market. The report further studies on the value, volume trends, and the pricing history of the market. In addition to it, various growth factors, restraints, and opportunities are also analyzed for the market to study the in-depth understanding of the market.

Key Players

The report has profiled some of the Important players prevalent in the global like – 3M, Honeywell, Kimberly-clark
Cardinal Health
Ansell
Hakugen
DACH
CM
Gerson
Shanghai Dasheng
Yuanqin
Winner, and more.

This report covers the sales volume, price, revenue, gross margin, manufacturers, suppliers, distributors, intermediaries, customers, historical growth and future perspectives in the R95 & R100 Grade Protective Masks.

Request for Free Sample Report of “R95 & R100 Grade Protective Masks” Market @  https://www.wiseguyreports.com/sample-request/5171525-global-r95-r100-grade-protective-masks-market-research-report-2020

Market Segmentation based On Type, Application and Region:

The global R95 & R100 Grade Protective Masks is analyzed for different segments to arrive at an insightful analysis. Such segmentation has been done based on type, application, and region.

Based on type, the global R95 & R100 Grade Protective Masks Market is segmented into Flat-fold Type, Cup Style and other

Based on application, the R95 & R100 Grade Protective Masks Market is segmented into Individual, Medical Institutions, and Others.

Based on Detailed Regional Analysis, the regional segmentation has been carried out for regions of U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America. The report on WGR includes an in-depth study of the R95 & R100 Grade Protective Masks in each regional segment mentioned above.

Key Stakeholders 
R95 & R100 Grade Protective Masks Market Manufacturers 
R95 & R100 Grade Protective Masks Market Distributors/Traders/Wholesalers 
R95 & R100 Grade Protective Masks Market Subcomponent Manufacturers 
Industry Association 
Downstream Vendors

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/5171525-global-r95-r100-grade-protective-masks-market-research-report-2020

Major Key Points from Table of Content:

1 R95 & R100 Grade Protective Masks Market Overview
1.1 Product Overview and Scope of R95 & R100 Grade Protective Masks
1.2 R95 & R100 Grade Protective Masks Segment by Type
1.2.1 Global R95 & R100 Grade Protective Masks Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Flat-fold Type
1.2.3 Cup Style
1.3 R95 & R100 Grade Protective Masks Segment by Application
1.3.1 R95 & R100 Grade Protective Masks Sales Comparison by Application: 2020 VS 2026
1.3.2 Individual
1.3.3 Medical Institutions
1.4 Global R95 & R100 Grade Protective Masks Market Size Estimates and Forecasts
1.4.1 Global R95 & R100 Grade Protective Masks Revenue 2015-2026
1.4.2 Global R95 & R100 Grade Protective Masks Sales 2015-2026
1.4.3 R95 & R100 Grade Protective Masks Market Size by Region: 2020 Versus 2026

2 Market Competitions by Manufacturers

3 Production Capacities by Region

6 Company Profiles and Key Figures in R95 & R100 Grade Protective Masks Business
6.1 3M
6.1.1 Corporation Information
6.1.2 3M Description, Business Overview and Total Revenue
6.1.3 3M R95 & R100 Grade Protective Masks Sales, Revenue and Gross Margin (2015-2020)
6.1.4 3M Products Offered
6.1.5 3M Recent Development
6.2 Honeywell
6.2.1 Honeywell R95 & R100 Grade Protective Masks Production Sites and Area Served
6.2.2 Honeywell Description, Business Overview and Total Revenue
6.2.3 Honeywell R95 & R100 Grade Protective Masks Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Honeywell Products Offered
6.2.5 Honeywell Recent Development
6.3 Kimberly-clark
6.3.1 Kimberly-clark R95 & R100 Grade Protective Masks Production Sites and Area Served
6.3.2 Kimberly-clark Description, Business Overview and Total Revenue
6.3.3 Kimberly-clark R95 & R100 Grade Protective Masks Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Kimberly-clark Products Offered
6.3.5 Kimberly-clark Recent Development
6.4 Cardinal Health
6.4.1 Cardinal Health R95 & R100 Grade Protective Masks Production Sites and Area Served
6.4.2 Cardinal Health Description, Business Overview and Total Revenue
6.4.3 Cardinal Health R95 & R100 Grade Protective Masks Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Cardinal Health Products Offered
6.4.5 Cardinal Health Recent Development

and more

Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Continued…

NORAH TRENT
Wise Guy Reports
841-198-5042
email us here


Source: EIN Presswire

Health and Wellness Market to See Huge Growth by 2026 | Fonterraoperative Group, Gerber Products, Alberts Organic

Health and Wellness Market

Health and Wellness Market

Stay up-to-date with Global Health and Wellness market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth.”

— Nidhi Bhawsar

NEW JERSEY, USA, April 14, 2020 /EINPresswire.com/ — A new business intelligence report released by HTF MI with title "Global Health and Wellness Market Research Report 2018 by Manufacturers, Regions, Types and Applications" is designed covering micro level of analysis by manufacturers and key business segments. The Global Health and Wellness Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and quantitative detailing. Some of the key players profiled in the study are Aleias Gluten Free Foods LIC, Food For Life Baking, Doves Farm Foods, Cybex International Inc., Chiquita Brands International, Fonterraoperative Group, Gerber Products, Alberts Organic, Enjoy Life Natural Brands LLC, Dr. Sch r AG/SPA, Danone, Chr. Hansen A/S, Big Oz Industries & Clover Industries.

What's keeping Aleias Gluten Free Foods LIC, Food For Life Baking, Doves Farm Foods, Cybex International Inc., Chiquita Brands International, Fonterraoperative Group, Gerber Products, Alberts Organic, Enjoy Life Natural Brands LLC, Dr. Sch r AG/SPA, Danone, Chr. Hansen A/S, Big Oz Industries & Clover Industries Ahead in the Market? Benchmark yourself with the strategic moves and findings recently released by HTF MI
Get Free Sample Report + All Related Graphs & Charts @ : https://www.htfmarketreport.com/sample-report/1541783-global-health-and-wellness-market-3

Market Overview of Global Health and Wellness
If you are involved in the Global Health and Wellness industry or aim to be, then this study will provide you inclusive point of view. It’s vital you keep your market knowledge up to date segmented by Applications [Supermarket, Independent Stores, Drug Stores, Unorganized Stores, Single Brand Stores, Online Stores & Fitness equipment], Product Types [Health and wellness food, Wellness Tourism, Beauty and personal care products, Preventive and personalized health, Fitness equipment] and major players. If you have a different set of players/manufacturers according to geography or needs regional or country segmented reports we can provide customization according to your requirement.

This study mainly helps understand which market segments or Region or Country they should focus in coming years to channelize their efforts and investments to maximize growth and profitability. The report presents the market competitive landscape and a consistent in depth analysis of the major vendor/key players in the market along with impact of economic slowdown due to COVID.

Furthermore, the years considered for the study are as follows:
Historical year – 2014-2019
Base year – 2019
Forecast period** – 2020 to 2026 [** unless otherwise stated]

**Moreover, it will also include the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product services of key players.

The titled segments and sub-section of the market are illuminated below:
The Study Explore the Product Types of Health and Wellness Market: Health and wellness food, Wellness Tourism, Beauty and personal care products, Preventive and personalized health, Fitness equipment

Key Applications/end-users of Global Health and Wellness Market: Supermarket, Independent Stores, Drug Stores, Unorganized Stores, Single Brand Stores, Online Stores & Fitness equipment

Top Players in the Market are: Aleias Gluten Free Foods LIC, Food For Life Baking, Doves Farm Foods, Cybex International Inc., Chiquita Brands International, Fonterraoperative Group, Gerber Products, Albert?s Organic, Enjoy Life Natural Brands LLC, Dr. Sch r AG/SPA, Danone, Chr. Hansen A/S, Big Oz Industries & Clover Industries

Region Included are: China, USA, Europe, Japan, Korea, India, Southeast Asia & South America

Enquire for customization in Report @: https://www.htfmarketreport.com/enquiry-before-buy/1541783-global-health-and-wellness-market-3

Important Features that are under offering & key highlights of the report:
– Detailed overview of Health and Wellness market
– Changing market dynamics of the industry
– In-depth market segmentation by Type, Application etc
– Historical, current and projected market size in terms of volume and value
– Recent industry trends and developments
– Competitive landscape of Health and Wellness market
– Strategies of key players and product offerings
– Potential and niche segments/regions exhibiting promising growth
– A neutral perspective towards Health and Wellness market performance
– Market players information to sustain and enhance their footprint

Read Detailed Index of full Research Study at @ https://www.htfmarketreport.com/reports/1541783-global-health-and-wellness-market-3

Major Highlights of TOC:
Chapter One: Global Health and Wellness Market Industry Overview
1.1 Health and Wellness Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Health and Wellness Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview

Chapter Two: Global Health and Wellness Market Demand
2.1 Segment Overview
2.1.1 APPLICATION 1
2.1.2 APPLICATION 2
2.1.3 Other
2.2 Global Health and Wellness Market Size by Demand
2.3 Global Health and Wellness Market Forecast by Demand

Chapter Three: Global Health and Wellness Market by Type
3.1 By Type
3.1.1 TYPE 1
3.1.2 TYPE 2
3.2 Health and Wellness Market Size by Type
3.3 Health and Wellness Market Forecast by Type

Chapter Four: Major Region of Health and Wellness Market
4.1 Global Health and Wellness Sales
4.2 Global Health and Wellness Revenue & market share

Chapter Five: Major Companies List

Chapter Six: Conclusion

Buy the Latest Detailed Report @ https://www.htfmarketreport.com/buy-now?format=1&report=1541783

Key questions answered
• What impact does COVID-19 have made on Global Health and Wellness Market Growth & Sizing?
• Who are the Leading key players and what are their Key Business plans in the Global Health and Wellness market?
• What are the key concerns of the five forces analysis of the Global Health and Wellness market?
• What are different prospects and threats faced by the dealers in the Global Health and Wellness market?
• What are the strengths and weaknesses of the key vendors?

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Nidhi Bhawsar
HTF Market Intelligence Consulting Private Limited
+1 (206) 317 1218
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Ideagen and CompliancePath Extend Product Validation Partnership

Colin Smith Headshot Cropped

Ideagen Corporate Logo

Ideagen Plc (LSE:IDEA )

Ideagen and CompliancePath can reduce the validation headache for companies through our proven and tested risk-based methodology that has been successfully deployed on more than 100 projects”

— Hugh Devine, MD of CompliancePath

NOTTINGHAM, EAST MIDLANDS, UNITED KINGDOM, April 14, 2020 /EINPresswire.com/ — Leading global provider of governance, risk and compliance software, UK company Ideagen Plc, has agreed a partnership with CompliancePath to extend their on-going validation accelerator program to include all life science related software products.

CompliancePath is an end to end health and life science IT compliance and software validation service provider founded in the US in 2008. In 2018 the company opened a computer system validation and software quality assurance test centre in Glasgow, Scotland.

Life sciences and healthcare are highly regulated industries and any software used by companies operating in these fields needs to be validated for the intended use. In practice what this means is that when a company purchases software, such as Ideagen’s Q-Pulse or any other software application that impacts on patient safety or product quality, it has to be validated for the purpose it is going to be used for to ensure the company remains compliant with regulations. This can be a costly and time-consuming process and can become an unwelcome headache.

CompliancePath has been providing a fast-track, risk focused and GAMP based validation solution to the Ideagen Q-Pulse product for more than five years, significantly reducing cost and time to deployment for Q-Pulse customers. In addition, PleaseReview fast-track validation has been available for Ideagen customers since the beginning of 2020, with 90% of the validation activities being delivered remotely from CompliancePath’s Scottish test centre.

Hugh Devine, MD of CompliancePath, explained: “It was a natural evolution to extend our risk based remote delivery of validation services to existing Ideagen companies. Most Life Science customers who are using Q-Pulse or PleaseReview will have several other software applications that will require validation to meet their regulatory requirements. Our extended partnership of additional professional services to cover all software related validation needs will allow Ideagen’s customers to continue to save time and cost while being able to utilise the remote delivery of validation. CompliancePath’s customers will now have a one stop shop to harmonise all their off the shelf (COTS) commercial validation projects.

“By working together Ideagen and CompliancePath can reduce the validation headache for companies through our proven and tested risk-based methodology that has been successfully deployed on more than 100 projects with Ideagen to date.”

Colin Smith, Head of Sales at Ideagen said: “This partnership with CompliancePath is hugely exciting for us. The work being done by health and life sciences companies is truly ground-breaking and it is great to know that we can take some of the administrative burden away from them. Allowing them to focus on their core work, while at the same time giving them the comfort and confidence of knowing that the processes they are following are properly validated and compliant with current legislation, is crucially important to us.”

https://www.ideagen.com/company/news/ideagen-and-compliancepath-extend-product-validation-partnership

ENDS

Heather Astbury
Ideagen
+44 7340 158049
email us here


Source: EIN Presswire

Alliance Background, Names Brian McCaman as Director of Sales

Alliance Background Director of Sales

Alliance a Leading Provider of Background Screening Services is proud to announce that Brian McCaman will be joining them as the Director of Sales.

SAINT PETERSBURG, FLORIDA, UNITED STATES, April 14, 2020 /EINPresswire.com/ — Alliance Background LLC a Leading Provider of Employment and Volunteer Background Screening Services is proud to announce that Brian McCaman will be joining their expanding sales organization as its Director of Sales. Mr. McCaman is a graduate of San Diego State University and brings more than 14 years of sales experience, passion and success to Alliance’s leadership team. In his new role Brian will be responsible for in sales pipeline planning, relationship management, team mentorship, advancing business objectives, driving goal attainment and revenue growth.

In addition to building and leading sales organizations in the Insurance industry, Brian serves on the HR Tampa Board of Directors and resides in the Bay area with his wife, Ashley. Brian is a certified level 1 CrossFit trainer and an avid supporter of Feeding Tampa Bay, the Humane Society and St. Jude Children’s Research Hospital.

“Brian is a proven sales leader with a track record of developing and delivering customer-focused sales solutions. He is extremely achievement-oriented with strong experience in consultative sales, business development and large account acquisition.”
stated Brittany C. Bollinger, Alliance's Founder and President. "We are looking forward to having such a proven sales leader as Brian to lead our expanding sales team. I know that he will serve our clients & partners well and add value to the Alliance brand."

“I am thrilled to be joining such a forward-thinking organization” commented Mr. McCaman “I’m excited for the opportunity to add my talents to an already excelling team, Brittany and Alliance have proven to be out of the box thinkers and have challenged me to grow both personally and professionally.

About Alliance Background, LLC. Founded in 2018, Alliance Background leverages both a fresh point of view with years of industry experience, leading edge technology and a superior commitment to service. Alliance founder Brittany Bollinger is active in many associations and organizations including Junior Leagues International, Big Brothers Big Sisters, Delta Gamma and currently serves on the Board of HR Tampa. Ms. Bollinger previously served as the youngest elected board member to the National Association of Professional Background Screeners (NAPBS) now (PBSA).

Brittany Bollinger
Alliance Background LLC
+1 866-590-8715
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire